#RBIVsGovt #Rupee #Disruptors

Receive Free News and Updates

SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD FEB 05
MCX SILVER MAR 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD FEB 05
MCX SILVER MAR 05
MCX CRUDEOIL DEC 18
MCX NATURALGAS DEC 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

Indian market ends with minor gains, Nifty holds 10,800

Global Markets: Asian shares wobbly, euro steady after ECB ends QE

US oil prices inch up amid stockpile drop, signs of easing trade tensions

Rupee gains 30 paise to 71.70 a dollar in opening trade

Oct 11, 2018 12:09 PM IST | Business

Orchid Pharmaceuticals investment was a mistake, says billionaire Adar Poonawalla

No merit in acquiring Panacea Biotech: Adar Poonawalla

Promoter of Panacea Biotech want to continue running the company: Adar Poonawalla

No plans to do anything with stake in Panacea Biotech: Adar Poonawalla

Billionaire Adar Poonawalla, the CEO of one of the world's largest vaccine maker Serum Institute of India, also has regrets. In an interaction with CNBC-TV18, Poonawalla said his biggest mistake was investing in Orchid Pharma.

"Investments in Orchid Pharmaceuticals was perhaps the single mistake we have ever made," said Adar Poonawalla on Thursday.

Adar's father Cyrus Poonawalla and his affiliated firms had acquired around 14 percent stake in Orchid over a period of time. Cyrus had later filed a Company Petition alleging certain acts of oppression and mismanagement in the affairs of Orchid Pharma .

When asked about acquiring Orchid, he said, “We tried to but we had issues with the existing CEO and promoter and that didn’t work out.”

“The debt that they kept taking was without anyone’s consent and they sort of went further into a mess. We just now are getting out of it at whatever value we can,” he said.

Talking about his investments and tie-ups with companies in the listed space, Adar Poonawala said his nearly 15 percent stake in Panacea Biotech is just strategic while tie-up with Cipla is only limited to South Africa.

On the business front, Poonawala said, “We are going to stick to making vaccines and at the most diversify into our new NBFC that we have formed to enter the financial services area.”

Have you signed up for Primo, our daily newsletter? It has all the stories and data on the market, business, economy and tech that you need to know.

Published Date: Oct 11th, 2018 09:16 AM | Updated Date: Oct 11, 2018 12:09 PM IST

You May Also Like

Gold dips to 1-week low as dollar bounces on strong data

Gold dips to 1-week low as dollar bounces on strong data

Superyacht in Malaysia's 1MDB scandal can be yours for $130 million

Superyacht in Malaysia's 1MDB scandal can be yours for $130 million

IL&FS owns 8 Audis, 6 BMWs, 2 Jaguars and 1 Lexus. They are all on sale

IL&FS owns 8 Audis, 6 BMWs, 2 Jaguars and 1 Lexus. They are all on sale

Trending on CNBC-TV18

Live TV

recommended for you